Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed the NSE that the trading window for dealing in the company's shares has been closed in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. A trading window closure means directors, key managerial personnel, and other designated insiders are restricted from buying or selling the company's stock during this period. Such closures are typically announced ahead of quarterly results, board meetings, or other material events to prevent insider trading. The exact reopening date and the specific event prompting the closure were not mentioned in the headline.
This is a routine compliance disclosure and does not directly impact the stock price. However, it often signals that a material announcement, such as financial results, may be forthcoming, which investors should watch for.